Talvy | $2,000,000 | (Mar 11, 2026)
Unreasonable Labs | $13,500,000 | (Mar 11, 2026)
Sigma360 | $17,000,000 | (Mar 11, 2026)
Certified by Founder
Lodge
INNOVENTRIC
start up
Israel
- Rehovot
- 30/10/2024
- Series B
- $28,500,000
Innoventric is a Structural Heart medical device company specializing in the development of percutaneous heterotopic cross-caval solutions for Tricuspid Regurgitation and right heart disease.
http://www.innoventric.com
#TTVR #Cardiology #MedTech #InterventionalCardiology #heterotopic #crosscaval #medicaldevices
- Industry Medical Device
- Website https://innoventric.com/
- LinkedIn https://www.linkedin.com/company/innoventric/
Verdant Impact | $3,000,000 | (Mar 11, 2026)
Imperium Technologies, Inc | $2,000,000 | (Mar 11, 2026)
Lux Aeterna | $10,000,000 | (Mar 11, 2026)
Axiom Trust Company | $11,800,000 | (Mar 11, 2026)
Sandbar | $23,000,000 | (Mar 11, 2026)
Jazz | $61,000,000 | (Mar 11, 2026)